{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:46:24Z","timestamp":1777416384213,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s13730-020-00554-x","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T19:03:12Z","timestamp":1609786992000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spontaneous remission of minimal change nephrotic syndrome in an elderly man"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-1619","authenticated-orcid":false,"given":"Yuki","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Kin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan nephrotic syndrome cohort study (JNSCS). Clin Exp Nephrol. 2020;24:526\u201340.","journal-title":"Clin Exp Nephrol"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0272-6386(12)80353-2","volume":"17","author":"S Fujimoto","year":"1991","unstructured":"Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17:687\u201392.","journal-title":"Am J Kidney Dis"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10157-007-0484-5","volume":"11","author":"T Takei","year":"2007","unstructured":"Takei T, Koike M, Suzuki K, et al. The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clin Exp Nephrol. 2007;11:214\u20137.","journal-title":"Clin Exp Nephrol"},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2169\/internalmedicine.53.1669","volume":"53","author":"H Kikuchi","year":"2014","unstructured":"Kikuchi H, Aoyagi M, Nagahama K, et al. Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch. Intern Med. 2014;53:1131\u20135.","journal-title":"Intern Med"},{"key":"554_CR6","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2169\/internalmedicine.55.6885","volume":"55","author":"A Yamashiro","year":"2016","unstructured":"Yamashiro A, Uchida T, Ito S, Oshima N, Oda T, Kumagai H. Complete remission of minimal change disease following an improvement of lung mycobacterium avium infection. Intern Med. 2016;55:2669\u201372.","journal-title":"Intern Med"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12882-018-0961-y","volume":"19","author":"A Haruki","year":"2018","unstructured":"Haruki A, Ishikawa E, Katayama K, et al. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection. BMC Nephrol. 2018;19:162.","journal-title":"BMC Nephrol"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/bmj.3.5720.421","volume":"3","author":"DA Black","year":"1970","unstructured":"Black DA, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970;3:421\u20136.","journal-title":"Br Med J"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"AK McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1378\/chest.12-1446","volume":"143","author":"DJF Stuijver","year":"2013","unstructured":"Stuijver DJF, Majoor CJ, Van Zaane B, et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest. 2013;143:1337\u201342.","journal-title":"Chest"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10157-014-1022-x","volume":"19","author":"H Yokoyama","year":"2015","unstructured":"Yokoyama H, Sugiyama H, Narita I, et al. Outcomes of primary nephrotic syndrome in elderly japanese: retrospective analysis of the Japan renal biopsy registry (J-RBR). Clin Exp Nephrol. 2015;19:496\u2013505.","journal-title":"Clin Exp Nephrol"},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","volume":"11","author":"SK Mak","year":"1996","unstructured":"Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Trans. 1996;11:2192\u2013201.","journal-title":"Nephrol Dial Trans"},{"key":"554_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.14797\/mdcj-14-3-237","volume":"14","author":"W Sharp","year":"2018","unstructured":"Sharp W, Olivero JJ. Venous thrombosis in nephrotic syndrome. Methodist Debakey Cardiovasc J. 2018;14:237\u20138.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"554_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503\u201312.","journal-title":"Am J Kidney Dis"},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.04160413","volume":"9","author":"C Ponticelli","year":"2014","unstructured":"Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy-a modern view. Clin J Am Soc Nephrol. 2014;9:609\u201316.","journal-title":"Clin J Am Soc Nephrol"},{"key":"554_CR16","first-page":"223","volume":"14","author":"AV Moorthy","year":"1980","unstructured":"Moorthy AV, Zimmerman SW. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. Clin Nephrol. 1980;14:223\u20139.","journal-title":"Clin Nephrol"},{"key":"554_CR17","first-page":"93","volume":"46","author":"K Kanahara","year":"1997","unstructured":"Kanahara K, Yorioka N, Kumagai J, et al. A case of nephrotic syndrome with rapid spontaneous remission in an elderly patient. Hiroshima J Med Sci. 1997;46:93\u20137.","journal-title":"Hiroshima J Med Sci"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/ndt\/14.10.2527","volume":"14","author":"I I\u015flek","year":"1999","unstructured":"I\u015flek I, G\u00f6k F, Albayrak D, K\u00fc\u00e7\u00fck\u00f6d\u00fck S. Nephrotic syndrome following cefixime therapy in a 10-month-old girl: spontaneous resolution without corticosteroid treatment. Nephrol Dial Transplant. 1999;14:2527.","journal-title":"Nephrol Dial Transplant"},{"key":"554_CR19","first-page":"265","volume":"22","author":"P Ferrara","year":"2012","unstructured":"Ferrara P, Gatto A, Vitelli O, Liberatore P, Del Bufalo F, Bottaro G. Nephrotic syndrome following H1N1 influenza in a 3-year-old boy. Iran J Pediatr. 2012;22:265\u20138.","journal-title":"Iran J Pediatr"},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000183647","volume":"42","author":"CY Lin","year":"1986","unstructured":"Lin CY, Hsu HC. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection. Nephron. 1986;42:110\u20135.","journal-title":"Nephron"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1001\/archinte.1984.04400020209039","volume":"144","author":"MA Kron","year":"1984","unstructured":"Kron MA, Hedger R. Hepatitis A-induced remission of minimal change nephropathy. Arch Intern Med. 1984;144:2279\u201380.","journal-title":"Arch Intern Med"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556\u201360.","journal-title":"Lancet"},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007;18:1476\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00467-004-1438-8","volume":"19","author":"W Cheung","year":"2004","unstructured":"Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2004;19:627\u201332.","journal-title":"Pediatr Nephrol"},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM, et al. Urinary CD80 Is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int. 2010;78:296\u2013302.","journal-title":"Kidney Int"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semnephrol.2011.06.002","volume":"31","author":"T Ishimoto","year":"2011","unstructured":"Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ. Minimal change disease: a CD80 podocytopathy? Semin Nephrol. 2011;31:320\u20135.","journal-title":"Semin Nephrol"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"e81836","DOI":"10.1172\/jci.insight.81836","volume":"2","author":"AH Kim","year":"2017","unstructured":"Kim AH, Chung JJ, Akilesh S, et al. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight. 2017;2:e81836.","journal-title":"JCI Insight"},{"key":"554_CR28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, et al. Induction of B7\u20131 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113:1390\u20137.","journal-title":"J Clin Invest"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.5414\/CNP71608","volume":"71","author":"A Komatsuda","year":"2009","unstructured":"Komatsuda A, Wakui H, Iwamoto K, et al. GATA-3 Is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome. Clin Nephrol. 2009;71:608\u201316.","journal-title":"Clin Nephrol"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1097\/MD.0000000000000300","volume":"93","author":"Y Iwabuchi","year":"2014","unstructured":"Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore). 2014;93:e300.","journal-title":"Medicine (Baltimore)"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10157-015-1139-6","volume":"20","author":"Y Miyabe","year":"2016","unstructured":"Miyabe Y, Takei T, Iwabuchi Y, Moriyama T, Nitta K. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Clin Exp Nephrol. 2016;20:103\u201310.","journal-title":"Clin Exp Nephrol"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000486930","volume":"195","author":"Y Iwabuchi","year":"2018","unstructured":"Iwabuchi Y, Moriyama T, Itabashi M, Takei T, Nitta K. Rituximab as a therapeutic option for steroid-sensitive minimal change nephrotic syndrome in adults. Contrib Nephrol. 2018;195:12\u20139.","journal-title":"Contrib Nephrol"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jth.12652","volume":"12","author":"CF Christiansen","year":"2014","unstructured":"Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney Disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12:1449\u201354.","journal-title":"J Thromb Haemost"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","volume":"117","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, Ten Kate MK, Waanders F, et al. High Absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224\u201330.","journal-title":"Circulation"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11255-013-0574-0","volume":"46","author":"G Ismail","year":"2014","unstructured":"Ismail G, Mircescu G, Ditoiu AV, Tacu BD, Jurubita R, Harza M. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int Urol Nephrol. 2014;46:787\u201392.","journal-title":"Int Urol Nephrol"},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2215\/CJN.04250511","volume":"7","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7:43\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1681\/ASN.2007030308","volume":"19","author":"K Wattanakit","year":"2008","unstructured":"Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19:135\u201340.","journal-title":"J Am Soc Nephrol"},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/asheducation-2016.1.188","volume":"2","author":"C Ribic","year":"2016","unstructured":"Ribic C, Crowther M. Thrombosis and anticoagulation in the setting of renal or liver disease hematology. Am Soc Hematol Educ Program. 2016;2:188\u201395.","journal-title":"Am Soc Hematol Educ Program"},{"key":"554_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2369-13-107","volume":"13","author":"S Kumar","year":"2012","unstructured":"Kumar S, Chapagain A, Nitsch D, Yaqoob MM. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol. 2012;13:107.","journal-title":"BMC Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00554-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-020-00554-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00554-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T13:22:33Z","timestamp":1670678553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-020-00554-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00554-x","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient described in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}